Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Exp Mol Pathol ; 115: 104475, 2020 08.
Artículo en Inglés | MEDLINE | ID: mdl-32473154

RESUMEN

The transcription factor EB (TFEB) is known for its role in lysosomal biogenesis, and it coordinates this process by driving autophagy and lysosomal gene expression during ischemia. In the present study, we aimed to explore the role of the TFEB-regulated autophagolysosome pathway (ALP) in rats with chronic cerebral ischemia (CCI) that were treated with remote ischemic postconditioning (RIPC). A modified 2-vessel occlusion (2-VO) method was utilized to establish the CCI rat model, and the CCI rats were identified by the Morris water maze test and histological staining. After the CCI rats were treated with RIPC, the damage to the rat cortex and hippocampal tissues and the status of the ALP were determined. Western blot analysis and immunofluorescence assays were performed to observe the nuclear translocation of TFEB. The rats were injected with TFEB siRNA via the lateral ventricle to investigate the effect of TFEB siRNA on the RIPC-treated CCI rats. The results suggested that RIPC of the CCI rats alleviated nerve injury, induced TFEB translocation into the nucleus, upregulated autophagy-related protein expression, and activated ALP machinery. Furthermore, TFEB siRNA decreased the levels of TFEB and impaired the neuroprotective effects of RIPC on the CCI rats. Collectively, we highlighted that RIPC attenuates damage in CCI rats via the activation of the TFEB-mediated ALP.


Asunto(s)
Autofagosomas/metabolismo , Factores de Transcripción Básicos con Cremalleras de Leucinas y Motivos Hélice-Asa-Hélice/metabolismo , Isquemia Encefálica/patología , Poscondicionamiento Isquémico , Lisosomas/metabolismo , Regulación hacia Arriba , Animales , Autofagosomas/ultraestructura , Encéfalo/patología , Encéfalo/ultraestructura , Enfermedad Crónica , Regulación hacia Abajo , Lisosomas/ultraestructura , Masculino , Tejido Nervioso/lesiones , Tejido Nervioso/patología , ARN Interferente Pequeño/metabolismo , Ratas Wistar
3.
Zhonghua Nei Ke Za Zhi ; 53(1): 23-6, 2014 Jan.
Artículo en Zh | MEDLINE | ID: mdl-24674723

RESUMEN

OBJECTIVE: To explore the clinical features of patients with vertebrobasilar dolichoectasia (VBD). METHODS: Patients diagnosed with posterior circulation ischemia in our hospital from October 2008 to January 2012 were consecutively collected and were divided into the VBD group and the non-VBD (NVBD) group. Clinical manifestations, risk factors, hemodynamic parameters and neuroimaging features were collected. RESULTS: (1) Statistical difference was observed in dyslipidemia, hypertension and the history of diabetes in the two groups (P < 0.05). (2) The cerebral hemodynamic features of the VBD patients were as the following: decreased peak systolic velocity of vertebral artery and basilar artery and decreased systolic/diastolic ratio. Statistical difference was showed in the average peak flow velocity (Vm), pulsatility index (PI) and resistance index (RI) (P = 0.036, 0.032, 0.032, respectively). (3) The main clinical manifestations of VBD were ischemic cerebrovascular disease, hemorrhagic cerebrovascular disease, oppression, brain damage symptoms and hydrocephalus. (4) The diagnosis in most of the VBD patients was confirmed by neural imaging and MRI was the first choice. CONCLUSION: The VBD patients have relative unique clinical features. MRI should be the first choice for neuroimaging.


Asunto(s)
Angiografía por Resonancia Magnética , Insuficiencia Vertebrobasilar/diagnóstico , Adulto , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad
4.
Mol Neurobiol ; 61(8): 4992-5001, 2024 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-38157120

RESUMEN

Neurodegenerative diseases, a group of debilitating disorders, have garnered increasing attention due to their escalating prevalence, particularly among aging populations. Alzheimer's disease (AD) reigns as a prominent exemplar within this category, distinguished by its relentless progression of cognitive impairment and the accumulation of aberrant protein aggregates within the intricate landscape of the brain. While the intricate pathogenesis of neurodegenerative diseases has been the subject of extensive investigation, recent scientific inquiry has unveiled a novel player in this complex scenario-transient receptor potential mucolipin 1 (TRPML1) channels. This comprehensive review embarks on an exploration of the intricate interplay between TRPML1 channels and neurodegenerative diseases, with an explicit spotlight on Alzheimer's disease. It immerses itself in the intricate molecular mechanisms governing TRPML1 channel functionality and elucidates their profound implications for the well-being of neurons. Furthermore, the review ventures into the realm of therapeutic potential, pondering the possibilities and challenges associated with targeting TRPML1 channels as a promising avenue for the amelioration of neurodegenerative disorders. As we traverse this multifaceted terrain of neurodegeneration and the enigmatic role of TRPML1 channels, we embark on a journey that not only broadens our understanding of the intricate machinery governing neuronal health but also holds promise for the development of innovative therapeutic interventions in the relentless battle against neurodegenerative diseases.


Asunto(s)
Mutación , Enfermedades Neurodegenerativas , Canales de Potencial de Receptor Transitorio , Humanos , Canales de Potencial de Receptor Transitorio/metabolismo , Canales de Potencial de Receptor Transitorio/genética , Enfermedades Neurodegenerativas/genética , Enfermedades Neurodegenerativas/metabolismo , Enfermedades Neurodegenerativas/patología , Animales , Mutación/genética , Enfermedad de Alzheimer/genética , Enfermedad de Alzheimer/metabolismo , Enfermedad de Alzheimer/patología
5.
Folia Neuropathol ; 61(4): 426-432, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-38174683

RESUMEN

Parkinson's disease (PD) is a chronic neuronal loss of dopamine and drugs used for its management has several limitations. The present report determines the effect of exercise on mitochondrial autophagy against PD. Parkinson's disease was induced by 15 doses of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP; 30 mg/kg, i.p.) for 3 weeks, on five consecutive days in a week. Exposure of exercise was provided for 40 min for a period of 2 weeks after PD confirmation. Assessment of behaviour was performed to evaluate the effect of exercise on motor function and cognitive function in PD rats. Levels of reactive oxygen species (ROS) and inflammatory cytokines were assessed in PD rats using enzyme linked immunosorbent assay (ELISA). Expression of myocyte-specific enhancer factor 2D (MEF2D) and NADH dehydrogenase 6 (ND6) was estimated in PD rats. Exposure to exercise ameliorates the altered motor function and cognitive function in PD rats. There was a reduction in ROS and cytokine levels in the brain tissue of the exercise group compared to the negative control group. Exercise ameliorates the altered expression of apoptotic proteins and mRNA expression of MEF2D and ND6 in the brain tissue of MPTP induced PD rats. In conclusion, data of study reveal that exercise protects the mitochondrial autophagy in PD rats by reducing inflammatory cytokines and oxidative stress.


Asunto(s)
Intoxicación por MPTP , Enfermedad de Parkinson , Ratas , Animales , Ratones , Intoxicación por MPTP/inducido químicamente , Intoxicación por MPTP/metabolismo , Especies Reactivas de Oxígeno/metabolismo , Autofagia/fisiología , Citocinas/metabolismo , Ratones Endogámicos C57BL , Modelos Animales de Enfermedad , Neuronas Dopaminérgicas
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA